Matrix Capital Management Company, LP

Holdings History for Adaptimmune Therapeutics PLC - Ordinary Shares, par value GBP 0.001 per share (ADAP)

Symbol: ADAP on Nasdaq
Investment type: Equity - Shares of Stock
Class: Ordinary Shares, par value GBP 0.001 per share
Latest Disclosed Ownership: 0 shares
Security Ownership: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Matrix Capital Management Company LP ownership in Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP)

2025-01-08 - Matrix Capital Management Company LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP). This represents 0% percent ownership of the company. In their previous filing dated 2024-12-05, Matrix Capital Management Company, LP had reported owning 135M shares, indicating a decrease of -100% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Matrix Capital Management Company LP	0%	-97.8%		0	-135,000,000	-100%	$0.20	13G/A	12/31/2024	8 Jan 2025 10:30:10
Matrix Capital Management Company LP	8.8%		$26.6M	135M			$0.20	13G/A	11/30/2024	5 Dec 2024 17:17:56

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024		-1.71%	$0	0	-37,681,515	-100%		Q4 2024
9/30/2024	1.71%	-0.06%	$35.8M	37.7M	-1,292,670	-3.32%	$0.95	Q3 2024
6/30/2024	0.29%		$38M	39M			$0.97	Q2 2024
3/31/2024	0.57%		$61.6M	39M			$1.58	Q1 2024
12/31/2023	0.32%		$30.9M	39M			$0.79	Q4 2023
9/30/2023	0.36%		$30.4M	39M			$0.78	Q3 2023
6/30/2023	0.42%		$36.1M	39M			$0.93	Q2 2023
3/31/2023	0.58%		$42.5M	39M			$1.09	Q1 2023
12/31/2022	1.09%		$56.9M	39M			$1.46	Q4 2022
9/30/2022	0.8%		$41.9M	39M			$1.08	Q3 2022
6/30/2022	1.5%		$66.3M	39M			$1.70	Q2 2022
3/31/2022	0.96%		$80.3M	39M			$2.06	Q1 2022
12/31/2021	1.63%		$146M	39M			$3.75	Q4 2021
9/30/2021	2.29%		$201M	39M			$5.17	Q3 2021
6/30/2021	1.81%		$166M	39M			$4.26	Q2 2021
3/31/2021	2.39%		$207M	39M			$5.31	Q1 2021
12/31/2020	2.27%		$210M	39M			$5.39	Q4 2020
9/30/2020	4.13%		$311M	39M			$7.98	Q3 2020
6/30/2020	6.08%	+0.71%	$390M	39M	+4,545,455	+13.2%	$10.01	Q2 2020
3/31/2020	2.39%	+0.45%	$93.6M	34.4M	+6,428,730	+23%	$2.72	Q1 2020
12/31/2019	0.72%		$33.6M	28M			$1.20	Q4 2019
9/30/2019	1.04%		$42.3M	28M			$1.51	Q3 2019
6/30/2019	2.08%		$113M	28M			$4.02	Q2 2019
3/31/2019	3.21%	+0.1%	$120M	28M	+851,000	+3.13%	$4.30	Q1 2019
12/31/2018	5.17%	+1.29%	$156M	27.1M	+6,786,989	+33.3%	$5.75	Q4 2018
9/30/2018	6.82%	+2.1%	$276M	20.4M	+6,278,500	+44.6%	$13.56	Q3 2018
6/30/2018	4.75%	+0.07%	$167M	14.1M	+201,500	+1.45%	$11.87	Q2 2018
3/31/2018	5.42%	+0.65%	$156M	13.9M	+1,668,500	+13.7%	$11.23	Q1 2018
12/31/2017	2.91%	+0.04%	$81.6M	12.2M	+170,000	+1.41%	$6.68	Q4 2017
9/30/2017	3.15%	+0.88%	$98.6M	12M	+3,351,428	+38.6%	$8.19	Q3 2017
6/30/2017	1.33%	+1.33%	$39M	8.69M	+8,692,083	NEW	$4.49	Q2 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.